Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis

Fly (Austin). 2022 Dec;16(1):275-298. doi: 10.1080/19336934.2022.2087484.

Abstract

The use of Drosophila in neurodegenerative disease research has contributed to the identification of modifier genes for the pathology. The basis for neurodegenerative disease occurrence in Drosophila is the conservation of genes across species and the ability to perform rapid genetic analysis using a compact brain. Genetic findings previously discovered in Drosophila can reveal molecular pathologies involved in human neurological diseases in later years. Disease models using Drosophila began to be generated during the development of genetic engineering. In recent years, results of reverse translational research using Drosophila have been reported. In this review, we discuss research on neurodegenerative diseases; moreover, we introduce various methods for quantifying neurodegeneration in Drosophila.

Keywords: Drosophila; neurodegenerative diseases; reverse translational research.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Drosophila* / genetics
  • Neurodegenerative Diseases* / genetics

Grants and funding

This work was supported by the Japan Agency for Medical Research and Development (AMED) [JP22ek019484s]; The Ministry of Education, Culture, Sports, Science and Technology of Japan [#19K22592 and #21H02837]; GSK Japan Research Grant 2022 [AS2021A000166849]; The Ministry of Education, Culture, Sports, Science and Technology of Japan [#18K14835, #18J00367 and #21K15619].